fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd

Updated on May 13, 2019

Stock/Share Code - DRREDDY

Dr. Reddys Laboratories is a leading India-based pharmaceutical company. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and New Chemical Entities (NCEs).

Below is the details of DRREDDY Dr Reddys Laboratories Ltd

Market Cap₹43,701 Cr.
Current Price ₹2,745 as on 17 May 19
52 Week High / Low Price₹2,875 / ₹1,888
Face Value₹5
Stock P/E34.93
Book Value₹725.78
Dividend Yield0.76 %
ROCE5.09 %
ROE4.58 %
Sales Growth (3yrs)-2.22 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has been maintaining a healthy dividend payout of 35.78%
Cons: Stock is trading at 3.63 times its book value The company has delivered a poor growth of 2.26% over past five years. Promoter holding is low: 26.77% Company has a low return on equity of 9.35% for last 3 years.

Dr Reddys Laboratories Ltd Price Chart

Dr Reddys Laboratories Ltd Price Chart

Dr Reddys Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Piramal Enterp. ₹2,132.8 8.18 ₹42,817.87 Cr. 1.05 ₹603.98 Cr. 23.03 22.07 3489.08 8.85
2. Sun Pharma.Inds. ₹148.3 22.89 ₹106,806.4 Cr. 0.45 ₹1,461.03 Cr. 310.00 16.34 7740.19 10.41
3. Aurobindo Pharma ₹670.45 17.77 ₹41,719.55 Cr. 0.35 ₹712.22 Cr. 22.97 21.53 5269.67 22.85
4. Cadila Health. ₹249.65 16.48 ₹32,626.67 Cr. 1.10 ₹510.7 Cr. -6.00 9.75 3577.90 18.28
5. Dr Reddy's Labs 24.73 ₹43,701.41 Cr. 0.76 ₹500.3 Cr. 65.28 0.80 3864.60 7.75
6. Cipla ₹544.15 32.21 ₹44,680.04 Cr. 0.54 ₹332.2 Cr. -17.06 2.39 4007.54 9.64
7. Dr Reddy's Labs 34.93 ₹43,701.41 Cr. 0.76 ₹399.4 Cr. 34.52 8.27 2731.70 5.09
8. Strides Pharma ₹414.1 4.39 ₹3,769.14 Cr. 0.47 ₹293.42 Cr. 234.73 6.10 794.50 16.15

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Dr Reddys Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018
Sales2,3782,1642,6282,5682,3602,0902,2542,5232,4922,6182,6312,732
YOY Sales Growth %-11.54%-14.34%-9.93%4.85%-0.77%-3.42%-14.2%-1.77%5.6%25.26%16.71%8.27%
Expenses2,3751,9282,0811,9282,0511,9411,9411,9882,1662,0432,0662,045
Material Cost %28.78%24.4%25.26%22.53%30.54%27.41%29.35%25.64%30.08%26.25%26.84%28.5%
Employee Cost %18.17%21.65%18.28%18.78%15.77%21.56%20.07%18.89%18.59%17.84%19.12%17.27%
Operating Profit4236547641309148314536326575565687
OPM %0%11%21%25%13%7%14%21%13%22%21%25%
Other Income12739264896049404873357593
Interest151312161616191314161616
Depreciation181172189184190191195198190192191194
Profit before tax-65442409529163-10140372196401433570
Tax %40%8%23%17%-36%28%28%20%10%18%20%30%
Net Profit-39409313439223-7101297177329346399
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales3,9563,3654,1594,5125,2436,7408,3709,72810,01110,2929,7209,35910,473
Sales Growth %97.21%-14.93%23.59%8.5%16.19%28.55%24.2%16.22%2.91%2.81%-5.56%-3.71%%
Expenses2,5212,7953,3093,4014,0525,1926,3856,9667,6208,2277,9498,0298,320
Material Cost %25.71%31.27%26.77%27.23%30.27%28.81%30.7%25.6%28.17%25.79%26.52%28.11%%
Manufacturing Cost %8.97%13.48%14.41%12.75%7.93%7.97%6.95%10.98%11.44%11.97%13.23%14.47%%
Employee Cost %6.61%10.34%9.46%10.87%13.36%12.85%13.6%14.6%14.89%16.45%18.55%19.69%%
Other Cost %22.44%27.98%28.93%24.51%25.73%27.41%25.03%20.44%21.62%25.72%23.48%23.52%%
Operating Profit1,4345708501,1111,1901,5481,9862,7622,3912,0651,7711,3302,153
OPM %36%17%20%25%23%23%24%28%24%20%18%14%21%
Other Income11719110121211982142152223325566204276
Interest52152716106961786464576362
Depreciation134162194222248301313380490650735774766
Profit before tax1,3665847301,0851,0521,2591,7532,4542,0601,6771,5446971,600
Tax %14%19%23%22%15%28%28%21%18%18%10%19%
Net Profit1,1774755618468939121,2661,9331,6791,3741,3845671,251
EPS in Rs69.4527.6232.2548.2550.9851.5771.98113.5694.4880.5683.4834.15
Dividend Payout %5%13%19%22%21%26%20%16%20%25%24%59%

Compounded Sales Growth

  • 10 Years:: 10.77%
  • 5 Years:: 2.26%
  • 3 Years:: -2.22%
  • TTM:: 13.50%

Compounded Profit Growth

  • 10 Years:: 1.21%
  • 5 Years:: -15.59%
  • 3 Years:: -31.03%
  • TTM:: 104.01%

Return on Equity

  • 10 Years:: 13.47%
  • 5 Years:: 12.77%
  • 3 Years:: 9.35%
  • TTM:: 4.58%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Sep 2018
Share Capital84848484858585858585838383
Equity Capital83.9684.184.284.484.684.884.985.185.285.382.983
Reserves4,2894,7285,1755,8305,9366,6337,6989,24410,54911,99311,51811,72511,969
Borrowings3304626405631,5361,5352,1002,6663,1263,0852,3552,5892,566
Other Liabilities1,0948771,2971,7861,7312,1702,1382,5362,7322,6642,7922,9572,583
Trade Payables598.49613.37801194.3604.3847.3890.91013.7920.8971.81031.71287.6993.1
Total Liabilities5,7986,1517,1968,2639,28710,42312,02214,53116,49217,82816,74817,35417,201
Fixed Assets6829871,2111,3161,6911,8972,3872,7483,2494,4384,8424,7174,607
Gross Block1291.191750.22157.32425.730253507.84208.74899.75815.675808675.49223.6
Accumulated Depreciation609.15762.8946.51110.1133416111821.72151.42566.23141.93833.34506.3
CWIP281246411745546618423576488616540675652
Investments8301,9311,7042,5552,4622,4782,3792,8063,8625,0763,1023,6363,295
Other Assets4,0052,9863,8703,6474,5885,4316,8328,4008,8927,6978,2648,3258,648
Inventories487.58640.9735.1897.41063.21326.71526.51592.11723.31699.61809.71856.81973.3
Trade receivables1055.7897.71419.71060.51770.51943.52963.94561.54711.73889.54405.44203.84898.6
Cash Equivalents1456.71536.7384.436866.2849919.1665.1901.4202.166.8120.7166.9
Loans n Advances1004.82911.11331.21321.4776.5679.61026.61045.81000.41427.91395.61520.981.6
Total Assets5,7986,1517,1968,2639,28710,42312,02214,53116,49217,82816,74817,35417,201

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity8865544861,2532461,4032899061,7862,7471,0161,539
Profit from operations1547.31744.5992.11440.61328.52140.42438.43472.62655.92765.12192.81661.3
Working Capital Changes-535.36-115.1-334.932.8-871-343.6-1773.8-2024.1-390.6379-854.151.3
Taxes paid-118.15-75.2-175.9-220.2-211.2-393.8-375.8-543-479.2-397.2-322.8-174
Cash from Investing Activity-397-1,520-744-1,117-609-425-524-874-2,031-1,9191,430-1,180
Fixed Assets Purchased-388.43-455.5-545.1-383-696.4-601.2-580.2-871.8-962.5-1083.7-985.1-768.9
Fixed Assets Sold82.82.918.72.90227.38.41.42.312.4
Investments purchased-74.6-2348.9-1373.3-2695.8-1162.4-1370.4-1186.5-3581-3594.6-6532.5-4850.2-6062
Investments sold33.191235.11634.92110.21260.211781262.63106.92609.66420.46952.75627.8
Cash from Financing Activity31746106-15261-19515228189-693-2,582-304
Proceeds from Shares1002.961.50.51.72.90.60.10.20.50.10.10.1
Proceeds from Borrowings114.75324.2636.6730.52103.32205.53026.54439.527372576.20165.4
Repayment of Borrowings-708.01-196-439.7-749.1-1221.8-2116.4-2516.5-3523-2122-2786.9-613.6-0.1
Interest Paid-49.36-9.8-18-12.1-4.2-62.9-87.5-82.8-68.7-75.1-63.6-70.6
Dividends Paid-43.75-73.7-73.8-123.2-814.1-221.6-270.8-297.9-357.4-407.3-335.3-399.2
Net Cash Flow806-920-152-16-302783-8460-56135-13554

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %36%12%13%18%15%17%20%23%16%12%11%5%
Debtor Days979712586123105129171172138165164
Inventory Turnover8.505.966.045.535.355.645.876.246.046.015.545.11

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Dr Reddys Laboratories Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.